secwatch.observer — SEC 8-K summary
======================================

Issuer:     ORAMED PHARMACEUTICALS INC. (ORMP)
CIK:        0001176309
Form:       8-K
Filed at:   2024-09-23T23:59:59+00:00
Accession:  0001213900-24-080812
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oramed & Scilex amend note: $2M prepayment, warrant exercise, liquidity waiver
------------------------------------------------------------------------------

- Scilex pays Oramed $2M Sept 23: $1.7M to March 2025 amort, $300K buys back 4M $11.50 warrants.
- Oramed can immediately exercise CS-5 Warrant for up to 1,062,500 Scilex shares; remaining half exercisable on original date.
- Minimum Liquidity covenant under Note reduced to $0 from Sept 19, 2024 until Maturity (March 21, 2025).
- $20M amortization payment due Sept 23, 2024 extended to Sept 30, 2024 without default.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1176309/000121390024080812/0001213900-24-080812-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1176309/000121390024080812/ea0215344-8k_oramed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-080812

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer